Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
3.740
-0.190 (-4.83%)
At close: Sep 10, 2025, 4:00 PM
3.680
-0.060 (-1.60%)
After-hours: Sep 10, 2025, 7:54 PM EDT
Cytek Biosciences Market Cap
Cytek Biosciences has a market cap or net worth of $475.82 million as of September 10, 2025. Its market cap has decreased by -35.96% in one year.
Market Cap
475.82M
Enterprise Value
237.47M
1-Year Change
-35.96%
Ranking
Category
Stock Price
$3.74
Market Cap Chart
Since the IPO on July 23, 2021, Cytek Biosciences's market cap has decreased from $2.26B to $475.82M, a decrease of -78.95%. That is a compound annual growth rate of -31.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2025 | 475.82M | -43.08% |
| Dec 31, 2024 | 835.98M | -32.38% |
| Dec 29, 2023 | 1.24B | -10.21% |
| Dec 30, 2022 | 1.38B | -36.91% |
| Dec 31, 2021 | 2.18B | -3.47% |
| Jul 23, 2021 | 2.26B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 663.10B |
| Johnson & Johnson | 429.00B |
| AbbVie | 370.61B |
| UnitedHealth Group | 290.04B |
| AstraZeneca | 251.37B |
| Novartis AG | 249.66B |
| Novo Nordisk | 242.52B |
| Abbott Laboratories | 230.09B |